BR0010739A - Processo de análise da predisposição genética de um paciente a pelo menos uma doença e amplificação de uma sequência e de duas sequências - Google Patents

Processo de análise da predisposição genética de um paciente a pelo menos uma doença e amplificação de uma sequência e de duas sequências

Info

Publication number
BR0010739A
BR0010739A BR0010739-5A BR0010739A BR0010739A BR 0010739 A BR0010739 A BR 0010739A BR 0010739 A BR0010739 A BR 0010739A BR 0010739 A BR0010739 A BR 0010739A
Authority
BR
Brazil
Prior art keywords
disease
patient
polymorphic region
resolution
amplification
Prior art date
Application number
BR0010739-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Bruno Mougin
Jean-Marie Tiercy
Original Assignee
Bio Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26234969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0010739(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9906599A external-priority patent/FR2793808B1/fr
Application filed by Bio Merieux filed Critical Bio Merieux
Publication of BR0010739A publication Critical patent/BR0010739A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BR0010739-5A 1999-05-20 2000-05-19 Processo de análise da predisposição genética de um paciente a pelo menos uma doença e amplificação de uma sequência e de duas sequências BR0010739A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9906599A FR2793808B1 (fr) 1999-05-20 1999-05-20 Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie
FR9915314A FR2793809B1 (fr) 1999-05-20 1999-12-06 Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede
PCT/FR2000/001385 WO2000071750A1 (fr) 1999-05-20 2000-05-19 Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede

Publications (1)

Publication Number Publication Date
BR0010739A true BR0010739A (pt) 2002-02-19

Family

ID=26234969

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010739-5A BR0010739A (pt) 1999-05-20 2000-05-19 Processo de análise da predisposição genética de um paciente a pelo menos uma doença e amplificação de uma sequência e de duas sequências

Country Status (12)

Country Link
US (1) US7060438B1 (enExample)
EP (1) EP1179091B2 (enExample)
JP (1) JP2003500067A (enExample)
CN (1) CN1351672A (enExample)
AT (1) ATE279535T1 (enExample)
AU (1) AU772175B2 (enExample)
BR (1) BR0010739A (enExample)
CA (1) CA2374440A1 (enExample)
DE (1) DE60014887T3 (enExample)
ES (1) ES2230109T5 (enExample)
FR (1) FR2793809B1 (enExample)
WO (1) WO2000071750A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2829580B1 (fr) 2001-09-07 2004-02-13 Bio Merieux Procede de lecture, de detection ou de quantification, hybrides ou complexes utilises dans ce procede et biopuce mettant en oeuvre ledit procede
WO2004047007A1 (en) 2002-11-15 2004-06-03 Bioarray Solutions, Ltd. Analysis, secure access to, and transmission of array images
EP1536021A1 (en) * 2003-11-27 2005-06-01 Consortium National de Recherche en Genomique (CNRG) Method for HLA typing
US7848889B2 (en) * 2004-08-02 2010-12-07 Bioarray Solutions, Ltd. Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
FR2881437B1 (fr) 2005-01-31 2010-11-19 Biomerieux Sa Procede pour le diagnostic/pronostic d'un syndrome septique
FR2906537A1 (fr) 2006-09-28 2008-04-04 Biomerieux Sa Procede de diagnostic in vitro du cancer broncho-pulmonaire par detection des transcrits majoritaires alternatifs du gene klk8 codant la kallicreine 8 et son utilisation pour le pronostic de survie
US20130096024A1 (en) * 2010-04-27 2013-04-18 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Method for detecting the susceptibility to develop adverse side effects related to bioimplants
EP2576815B1 (en) 2010-06-04 2018-02-14 Biomérieux Method for the prognosis of colorectal cancer
US9110079B2 (en) 2010-09-29 2015-08-18 Biomerieux Method and kit for establishing an in vitro prognosis on a patient exhibiting SIRS
WO2012129758A1 (en) 2011-03-25 2012-10-04 Biomerieux Method and kit for determining in vitro probability for individual to suffer from colorectal cancer
EP3000897B1 (en) 2013-05-21 2019-10-16 Biomérieux Colorectal cancer prognosis agent kit
EP3620984B1 (en) 2018-09-06 2024-04-10 Accenture Global Solutions Limited Digital quality control using computer visioning with deep learning
WO2025172242A1 (en) 2024-02-13 2025-08-21 bioMérieux Method of assessing the risk of death of a patient

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567809A (en) * 1986-03-13 1996-10-22 Hoffmann-La Roche Inc. Methods and reagents for HLA DRbeta DNA typing
US5468611A (en) * 1990-06-27 1995-11-21 The Blood Center Research Foundation, Inc. Method for HLA typing
NL9002259A (nl) * 1990-10-17 1992-05-18 Eurodiagnostics B V Werkwijze voor het bepalen van een genotype door het vergelijken van de nucleotidensequentie van leden van een genfamilie, alsmede kit voor het opsporen van genetische variaties.
GB9024005D0 (en) 1990-11-05 1990-12-19 British Bio Technology Process for amplifying nucleic acid
FR2679252B1 (fr) * 1991-07-17 1993-12-10 Bio Merieux Systeme de sondes permettant d'effectuer le typage hla dr, et procede de typage utilisant lesdites sondes.
US5976789A (en) * 1991-07-17 1999-11-02 Bio Merieux System of probes enabling HLA-DR typing to be performed, and typing method using said probes
JPH0690757A (ja) * 1991-08-23 1994-04-05 Kitasato Inst:The Hla−drタイピング用塩基配列群とそれを用いた hla−drタイピング法
JPH08308596A (ja) * 1995-03-10 1996-11-26 Wakunaga Pharmaceut Co Ltd Hlaの検出
US5939542A (en) 1995-03-10 1999-08-17 Wakunaga Seiyaku Kabushiki Kaisha Detection of HLA-DR
WO1997020070A1 (en) * 1995-11-29 1997-06-05 The Anthony Nolan Bone Marrow Trust Methods for separating and/or identifying dna molecules
FR2749308B1 (fr) * 1996-06-03 1998-07-24 Bio Merieux Sondes nucleotidiques et procede pour determiner le typage hla dqb1
AU6321998A (en) * 1997-02-11 1998-08-26 William H. Hildebrand Class i sequence based typing of hla-a, -b, and -c alleles by direct dna sequencing
EP0887423A1 (en) * 1997-06-26 1998-12-30 Biotest Ag A method for determining the Histocompatibility locus antigen class II
JP2001512694A (ja) * 1997-08-11 2001-08-28 ビジブル・ジェネティクス・インコーポレーテッド Dnaのhlaクラスiタイプを決定するための方法およびキット
US5910413A (en) * 1997-10-10 1999-06-08 Visible Genetics, Inc. Method and kit for amplification, sequencing and typing of classical HLA class I genes

Also Published As

Publication number Publication date
EP1179091A1 (fr) 2002-02-13
DE60014887T3 (de) 2009-09-24
AU772175B2 (en) 2004-04-08
ATE279535T1 (de) 2004-10-15
EP1179091B2 (fr) 2009-02-25
ES2230109T3 (es) 2005-05-01
EP1179091B1 (fr) 2004-10-13
AU4766000A (en) 2000-12-12
JP2003500067A (ja) 2003-01-07
FR2793809B1 (fr) 2006-07-28
FR2793809A1 (fr) 2000-11-24
US7060438B1 (en) 2006-06-13
CA2374440A1 (fr) 2000-11-30
WO2000071750A1 (fr) 2000-11-30
CN1351672A (zh) 2002-05-29
ES2230109T5 (es) 2009-06-05
DE60014887T2 (de) 2005-10-13
DE60014887D1 (de) 2004-11-18

Similar Documents

Publication Publication Date Title
LIU et al. Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders
JP4422897B2 (ja) 核酸を検出するためのプライマ伸長法
Álvarez-Iglesias et al. Coding region mitochondrial DNA SNPs: targeting east Asian and Native American haplogroups
US20030148301A1 (en) Method of detecting nucleotide polymorphism
EP1430150B1 (en) Diagnostic probe detection system
US20180195114A1 (en) Genetic markers for discrimination and detection of viruses causing infectious aquatic organism diseases, and method of discriminating and detecting the viruses using the same
US20060110765A1 (en) Detection of nucleic acid variation by cleavage-amplification (CleavAmp) method
DK2412718T3 (en) CIRCUIT PRIMES USED BY NUCLEIC ACID AMPLIFICATION AND USE THEREOF
BR0010739A (pt) Processo de análise da predisposição genética de um paciente a pelo menos uma doença e amplificação de uma sequência e de duas sequências
CA2306055A1 (en) Methods and oligonucleotides for detecting nucleic acid sequence variations
Petersen et al. Short PNA molecular beacons for real-time PCR allelic discrimination of single nucleotide polymorphisms
US8906620B2 (en) Exon grouping analysis
JP2002516666A (ja) 少なくとも一つの特定のヌクレオチド配列の増幅方法及び使用されるプライマー
Faas et al. Sequence‐specific priming and exonuclease‐released fluorescence detection of HLA‐DQB1 alleles
US9637788B2 (en) Discrimination of blood type variants
Voisey et al. SNP technologies for drug discovery: a current review
Hayashi Recent enhancements in SSCP
Honeyman et al. Development of a snapback method of single-strand conformation polymorphism analysis for genotyping Golden Retrievers for the X-linked muscular dystrophy allele
Nurmi et al. High-throughput genetic analysis using time-resolved fluorometry and closed-tube detection
Klintzsch et al. Detection of the nt230 [del4] MDR1 mutation in dogs by a fluorogenic 5′ nuclease TaqMan allelic discrimination method
US20050244830A1 (en) Quantitative multiplex amplification on a genomic scale, and applications for detecting genomic rearrangements
US20040121344A1 (en) Method of detecting nucleotide polymorphism
Attila et al. Prenatal diagnosis of sickle cell anemia in twin pregnancies and identification by VNTRs
Mirasena et al. The spectrum of β-thalassemia mutations in phitsanulok province: Development of multiplex ARMS for mutation Detection
Luo et al. Genotyping mitochondrial DNA single nucleotide polymorphisms by PCR ligase detection reactions.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]